They found that the protein levels of both BDNF and SYT1 in the model group were significantly lower than those in the control group (p < 0.01, Fig. 5), which suggests that decreases in BDNF and SYT1 may be involved in the degradation of nerve function in AD. Here, BDNF is linked to Alzheimer disease.